Parasympathetic activation by pyridostigmine on chemoreflex sensitivity in heart-failure rats

Autonomic Neuroscience: Basic and Clinical

Volumn 179, Issue 1-2, 2013, Pages 43-48

  Sabino, João Paulo J ^a   da Silva, Carlos Alberto Aguiar ^a   Giusti, Humberto ^a   Glass, Mogens Lesner ^a   Salgado, Helio C ^a   Fazan, Rubens ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Central chemoreflex; Heart failure; Peripheral chemoreflex; Pyridostigmine

Indexed keywords

CARBON DIOXIDE; OXYGEN; PYRIDOSTIGMINE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CHEMORECEPTOR REFLEX; CHEMOSENSITIVITY; CONTROLLED STUDY; HEART FAILURE; HEART FUNCTION; HEART RATE; HYPERCAPNIA; HYPOXIA; LUNG VENTILATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARASYMPATHETIC FUNCTION; PRIORITY JOURNAL; RAT; RAT MODEL; TIDAL VOLUME;

CENTRAL CHEMOREFLEX; HEART FAILURE; PERIPHERAL CHEMOREFLEX; PYRIDOSTIGMINE;

ANIMALS; ANOXIA; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART RATE; HYPERCAPNIA; MALE; PARASYMPATHETIC NERVOUS SYSTEM; PULMONARY VENTILATION; PYRIDOSTIGMINE BROMIDE; RATS; RATS, WISTAR;

EID: 84896371827     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2013.07.001     Document Type: Article

References (47)

1. Androne A.S., Hryniewicz K., Goldsmith R., Arwady A., Katz S.D. Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart 2003, 89:854-858.
2. Bartlett D., Tenney S.M. Control of breathing in experimental anemia. Respir. Physiol. 1970, 10:384-395.
3. Behling A., Moraes R.S., Rohde L.E., Ferlin E.L., Nóbrega A.C., Ribeiro J.P. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am. Heart J. 2003, 146:494-500.
4. Bibevski S., Dunlap M.E. Ganglionic mechanisms contribute to diminished vagal control in heart failure. Circulation 1999, 99:2958-2963.
5. Bibevski S., Dunlap M.E. Evidence for impaired vagus nerve activity in heart failure. Heart Fail. Rev. 2011, 16:129-135.
6. Blain G.M., Smith C.A., Henderson K.S., Dempsey J.A. Peripheral chemoreceptors determine the respiratory sensitivity of central chemoreceptors to CO(2). J. Physiol. 2010, 588:2455-2471.
7. Campanucci V.A., Nurse C.A. Autonomic innervation of the carotid body: role in efferent inhibition. Respir. Physiol. Neurobiol. 2007, 157:83-92.
8. Chua T.P., Clark A.L., Amadi A.A., Coats A.J. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J. Am. Coll. Cardiol. 1996, 27:650-657.
9. Chugh S.S., Chua T.P., Coats A.J.S. Peripheral chemoreflex in chronic heart failure: friend and foe. Am. Heart J. 1996, 132:900-904.
10. De Ferrari G.M., Crijns H.J., Borggrefe M., Milasinovic G., Smid J., Zabel M., Gavazzi A., Sanzo A., Dennert R., Kuschyk J., Raspopovic S., Klein H., Swedberg K., Schwartz P.J. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur. Heart J. 2011, 32:847-855. CardioFit Multicenter Trial Investigators.
11. Ding Y., Li Y.L., Zimmerman M.C., Schultz H.D. Elevated mitochondrial superoxide contributes to enhanced chemoreflex in heart failure rabbits. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R303-R311.
12. Ding Y., Li Y.L., Schultz H.D. Role of blood flow in carotid body chemoreflex function in heart failure. J. Physiol. 2011, 589:245-258.
13. Eyzaguirre C., Koyano H. Effects of electrical stimulation on the frequency of chemoreceptor discharges. J. Physiol. 1965, 178:438-462.
14. Fidone S.J., Sato A. Efferent inhibition and antidromic depression of chemoreceptor A-fibers from the cat carotid body. Brain Res. 1970, 22:181-193.
15. Guyenet P.G. Neural structures that mediate sympathoexcitation during hypoxia. Respir. Physiol. 2000, 121:147-162.
16. Kristen A.V., Just A., Haass M., Seller H. Central hypercapnic chemoreflex modulation of renal sympathetic nerve activity in experimental heart failure. Basic Res. Cardiol. 2002, 97:177-186.
17. Lahiri S., Forster R.E. CO2/H(+) sensing: peripheral and central chemoreception. Int. J. Biochem. Cell Biol. 2003, 35:1413-1435.
18. Li M., Zheng C., Sato T., Kawada T., Sugimachi M., Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004, 109:120-124.
19. Li Y.L., Xia X.H., Zheng H., Gao L., Li Y.F., Liu D., Patel K.P., Wang W., Schultz H.D. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc. Res. 2006, 71:129-138.
20. Liu J.L., Zucker I.H. Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circ. Res. 1999, 84:417-423.
21. Luz P.L., Shubin H., Weil M.H., Jacobson E., Stein L. Pulmonary edema related to changes in colloid osmotic and pulmonary artery wedge pressure in patients after acute myocardial infarction. Circulation 1975, 51:350-357.
22. Mancia G., Seravalle G., Giannattasio C., Bossi M., Preti L., Cattaneo B.M., Grassi G. Reflex cardiovascular control in congestive heart failure. Am. J. Cardiol. 1992, 69:17G-22G.
23. Murdoch C.E., Zhang M., Cave A.C., Shah A.M. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc. Res. 2006, 71:208-215.
24. Narkiewicz K., Pesek C.A., van de Borne P.J., Kato M., Somers V.K. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999, 100:262-267.
25. Nobrega A.C., Dos Reis A.F., Moraes R.S., Bastos B.G., Ferlin E.L., Ribeiro J.P. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin. Auton. Res. 2001, 11:11-17.
26. Pacher P., Nagayama T., Mukhopadhyay P., Bátkai S., Kass D.A. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat. Protoc. 2008, 3:1422-1433.
27. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 1979, 44:503-512.
28. Ponikowski P., Chua T.P., Anker S.D., Francis D.P., Doehner W., Banasiak W., Poole-Wilson P.A., Piepoli M.F., Coats A.J. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 2001, 104:544-549.
29. Reddy M.K., Schultz H.D., Zheng H., Patel K.P. Altered nitric oxide mechanism within the paraventricular nucleus contributes to the augmented carotid body chemoreflex in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H149-H157.
30. Sabino J.P.J., da Silva C.A.A., de Melo R.F., Fazan Junior R., Salgado H.C. The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure. Auton. Neurosci. 2013, 173:58-64.
31. Sabino J.P.J., de Oliveira M., Giusti H., Glass M.L., Fazan Junior R., Salgado H.C. Hemodynamic and ventilatory response to different levels of hypoxia and hypercapnia in carotid body-denervated rats. Clinics 2013, 68:395-399.
32. Schultz H.D., Li Y.L. Carotid body function in heart failure. Respir. Physiol. Neurobiol. 2007, 157:171-185.
33. Schultz H.D., Sun S.Y. Chemoreflex function in heart failure. Heart Fail. Rev. 2000, 5:45-56.
34. Soares P.P.S., Nóbrega A.C.L., Ushizima M.R., Irigoyen M.C.C. Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton. Neurosci. 2004, 113:24-31.
35. Sullivan M.J., Higginbotham M.B., Cobb F.R. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988, 77:552-559.
36. Sun S.Y., Wang W., Zucker I.H., Schultz H.D. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J. Appl. Physiol. 1999, 86:1264-1272.
37. Taylor P. Anticholinesterase agents. Goodman and Gilman's Pharmacological Basis of Therapeutics 2001, 175-192. McGraw-Hill, New York. J.G. Hardman, L.E. Limbird (Eds.).
38. Ueno H., Asanoi H., Yamada K., Oda Y., Takagawa J., Kameyama T., Hirai T., Nozawa T., Takashima S., Inoue H. Attenuated respiratory modulation of chemoreflex-mediated sympathoexcitation in patients with chronic heart failure. J. Card. Fail. 2004, 10:236-243.
39. Wang W., Chen J.S., Zucker I.H. Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ. Res. 1991, 68:1294-1301.
40. Wang W.Z., Gao L., Wang H.J., Zucker I.H., Wang W. Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the NTS AT1 receptors in heart failure. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1216-H1226.
41. Yamada K., Asanoi H., Ueno H., Joho S., Takagawa J., Kameyama T., Hirai T., Nozawa T., Inoue H. Role of central sympathoexcitation in enhanced hypercapnic chemosensitivity in patients with heart failure. Am. Heart J. 2004, 148:964-970.
42. Zhang Y., Popovic Z.B., Bibevski S., Fakhry I., Sica D.A., Van Wagoner D.R., Mazgalev T.N. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ. Heart Fail. 2009, 2:692-699.
43. Zheng C., Li M., Inagaki M., Kawada T., Sunagawa K., Sugimachi M. Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005, 7:7072-7075.
44. Zhu G.Q., Zucker I.H., Wang W. Central AT1 receptors are involved in the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Basic Res. Cardiol. 2002, 97:320-326.
45. Zucker I.H. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 2006, 48:1005-1011.
46. Zucker I.H., Liu J.L. Angiotensin II-nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail. Rev. 2000, 5:27-43.
47. Zucker I.H., Patel K.P., Schultz H.D. Neurohumoral stimulation. Heart Fail. Clin. 2012, 8:87-99.